NHS England is set to offer expedited access to the trial for BioNTech’s new cancer vaccine, BNT113-01, for individuals with advanced head and neck cancers. The trial is part of the NHS Cancer Vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results